Innometry Co Ltd

Innometry's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage profile. The company maintains a strong liquidity position with a current ratio of 3.12, supported by KRW 11.67 billion in cash and equivalents. However, the company reported negative net income of KRW 4.3 billion and operating income of KRW -5.7 billion, reflecting operational challenges. Profitability metrics show significant underperformance relative to industry norms. The company's return on equity (ROE) is -7.21%, and return on assets (ROA) is -5.58%, both well below the typical thresholds for industrial machinery firms. Gross profit of KRW 3.32 billion on revenue of KRW 38.57 billion suggests margin compression, likely due to competitive pricing pressures or rising production costs. The company's revenue is concentrated in a single business line focused on X-ray battery testing equipment, with no disclosed geographic diversification beyond domestic and international markets. This lack of segment or geographic diversification increases exposure to sector-specific demand fluctuations and regional economic shifts. Growth prospects appear muted, with no disclosed revenue growth in the latest period and negative operating and net income. The company's free cash flow is negative at KRW -3.48 billion, driven by capital expenditures of KRW -1.38 billion. While operating cash flow is positive at KRW 5.68 billion, it is insufficient to cover capital spending, signaling potential reinvestment challenges. Risk factors include the company's negative earnings and the absence of immediate liquidity or dilution flags. The low dilution risk is supported by no recent share issuance or shelf registration activity. However, the company's negative ROE and ROA suggest operational inefficiencies that could pressure future earnings. Recent filings and transcripts do not disclose material events or strategic shifts. The company's business model remains focused on X-ray battery testing equipment, with no indication of new product lines or market expansion in the latest available data.